Table 2. Effect estimates of WHELD intervention in comparison to TAU on primary outcome and key secondary outcome measures (multiple imputation analysis).
Outcome measure | Adjusted effect (SE)* | p-Value | Mean difference (SEM) | 95% CI of mean difference | Effect size (Cohen’s D) | Number needed to treat∆ |
---|---|---|---|---|---|---|
DEMQOL-Proxy (n = 553) | R = 0.12 Z = 2.82 | 0.0042 | 2.54+ (0.88) | 0.81, 4.28 | 0.24 | 9 |
CMAI (n = 553) | R = 0.11; Z = 2.68 | 0.0076 | 4.27+ (1.59) | −7.39, −1.15 | 0.23 | 6 |
NPI-NH (n = 547) | R = −1.5; Z = 3.52 | <0.001 | 4.55+ (1.28) | −7.07, −2.02 | 0.30 | 9 |
*Adjusted effect takes into account baseline value, age, sex, Clinical Dementia Rating, site, and clustering within care homes.
∆Based on binary outcome: better than mean overall outcome versus mean outcome or worse than overall mean outcome for DEMQOL and CMAI.
+DEMQOL: improvement in WHELD group from baseline to 9 months 4.78, improvement in TAU group 2.24, mean difference 2.54. CMAI: improvement in WHELD group from baseline to 9 months −4.13, worsening in TAU group 0.14, mean difference 4.27. NPI-NH: improvement in WHELD group from baseline to 9 months −2.64, worsening in TAU group 1.91, mean difference 4.55.
CMAI, Cohen-Mansfield Agitation Inventory; NPI-NH, Neuropsychiatric Inventory–Nursing Home Version; TAU, treatment as usual.